Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Related Citations for PubMed (Select 21621952)

1.

Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis.

Sugarbaker PH, Van der Speeten K, Anthony Stuart O, Chang D.

Eur J Surg Oncol. 2011 Aug;37(8):719-26. doi: 10.1016/j.ejso.2011.04.007. Epub 2011 May 31.

PMID:
21621952
2.

Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis.

Van der Speeten K, Stuart OA, Chang D, Mahteme H, Sugarbaker PH.

Cancer Chemother Pharmacol. 2011 Jul;68(1):147-56. doi: 10.1007/s00280-010-1460-4. Epub 2010 Sep 21.

PMID:
20857115
3.

Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis.

Chua TC, Liauw W, Zhao J, Morris DL.

Int J Clin Oncol. 2013 Jun;18(3):439-46. doi: 10.1007/s10147-012-0397-5. Epub 2012 Mar 14.

PMID:
22415741
4.

[Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].

Königsrainer I, Beckert S, Brücher B, Zieker D, Königsrainer A.

Dtsch Med Wochenschr. 2011 Sep;136(36):1811-4. doi: 10.1055/s-0031-1286108. Epub 2011 Aug 31. German.

PMID:
21882140
5.

Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Kuijpers AM, Mehta AM, Aalbers AG, van Driel WJ, Boot H, Verwaal VJ.

Eur J Surg Oncol. 2014 Aug;40(8):937-42. doi: 10.1016/j.ejso.2014.02.238. Epub 2014 Feb 28.

PMID:
24630923
6.
7.

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.

Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh HJ 3rd.

Cancer. 2010 Aug 15;116(16):3756-62. doi: 10.1002/cncr.25116.

8.

Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.

Ann Surg Oncol. 2008 Feb;15(2):526-34. Epub 2007 Nov 28.

PMID:
18043976
9.

Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin.

Mahteme H, Sugarbaker PH.

Br J Surg. 2004 Sep;91(9):1168-73.

PMID:
15449269
10.
11.

Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Kuijpers AM, Mehta AM, Boot H, van Leerdam ME, Hauptmann M, Aalbers AG, Verwaal VJ.

Ann Oncol. 2014 Apr;25(4):864-9. doi: 10.1093/annonc/mdu031.

PMID:
24667719
12.

Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin.

Winer J, Zenati M, Ramalingam L, Jones H, Zureikat A, Holtzman M, Lee K, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2014 May;21(5):1456-62. doi: 10.1245/s10434-013-3328-4. Epub 2013 Nov 8.

PMID:
24201745
13.

[Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy].

Glockzin G, Ghali N, Lang SA, Agha A, Schlitt HJ, Piso P.

Chirurg. 2007 Dec;78(12):1100, 1102-6, 1108-10. German.

PMID:
17992490
14.

Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.

Shen P, Levine EA, Hall J, Case D, Russell G, Fleming R, McQuellon R, Geisinger KR, Loggie BW.

Arch Surg. 2003 Jan;138(1):26-33.

PMID:
12511145
15.

Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.

Roviello F, Pinto E, Corso G, Pedrazzani C, Caruso S, Filippeschi M, Petrioli R, Marsili S, Mazzei MA, Marrelli D.

J Surg Oncol. 2010 Nov 1;102(6):663-70. doi: 10.1002/jso.21682.

PMID:
20721959
16.

Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.

Iversen LH, Rasmussen PC, Laurberg S.

Br J Surg. 2013 Jan;100(2):285-92. doi: 10.1002/bjs.8908. Epub 2012 Nov 2.

PMID:
23124619
18.

Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.

Quenet F, Goéré D, Mehta SS, Roca L, Dumont F, Hessissen M, Saint-Aubert B, Elias D.

Ann Surg. 2011 Aug;254(2):294-301. doi: 10.1097/SLA.0b013e3182263933.

PMID:
21772129
19.

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial.

Glockzin G, Rochon J, Arnold D, Lang SA, Klebl F, Zeman F, Koller M, Schlitt HJ, Piso P.

BMC Cancer. 2013 Feb 7;13:67. doi: 10.1186/1471-2407-13-67.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk